文献速递肝病消化道肿瘤与早癌

CPS1:多功能的线粒体酶、胆汁蛋白、急性肝损伤生物标志物与细胞因子

CPS1: a multipurpose mitochondrial enzyme, bile protein, acute liver injury biomarker, and cytokine.
PubMed 文献 · Gut · 2026-09-07

CPS1是肝细胞高丰度线粒体基质酶,催化尿素循环首步。它经线粒体囊泡顶端分泌入胆汁,生理下血清缺失,损伤时释放入血,半衰期1-2小时,是急性肝衰竭尤其是对乙酰氨基酚相关ALF的预后血清标志物,兼具免疫调节与非酶功能,并参与多种肿瘤代谢重编程。

要点

  • CPS1是急性肝衰竭的预后血清标志物,血清半衰期仅1-2小时。
  • CPS1经线粒体囊泡分泌入胆汁,损伤时选择性释放入血。
  • CPS1被单核细胞摄取后诱导抗炎细胞分化,保护损伤肝脏。

核心结论

  • CPS1兼具酶与非酶多重功能,具有重要生理、遗传病、诊断与潜在治疗意义。

研究设计与样本

  • 综述,系统阐述CPS1的酶学功能、分泌途径、生物标志物价值、免疫调节作用及肿瘤相关性。

主要发现

  • CPS1生理性经顶端分泌入胆汁,可能通过线粒体来源囊泡实现。
  • CPS1正常血清中缺失,经基底侧错位靶向和细胞损伤释放入血,急性肝衰竭时可检测到。
  • 损伤触发的CPS1释放较其他线粒体蛋白更具选择性,结合其丰度和1-2小时血清半衰期,成为预后标志物。
  • CPS1被循环单核细胞摄取,诱导抗炎细胞分化并归巢保护损伤肝脏,解释其快速周转。
  • CPS1在多种癌症中上调或下调,通过代谢重编程改变肿瘤微环境并影响生长进展。

关键数值与推荐

  • CPS1血清半衰期为1-2小时。
  • CPS1常染色体隐性突变导致CPS1缺乏症,因严重高氨血症致新生儿脑病和昏迷。
  • CPS1在人类对乙酰氨基酚相关急性肝衰竭中为预后血清标志物。

临床怎么用

  • 可将血清CPS1作为急性肝衰竭尤其对乙酰氨基酚相关ALF的预后评估指标。
  • 关注CPS1缺乏症所致新生儿高氨血症脑病的遗传诊断。
  • CPS1在肿瘤中的差异表达提示其作为代谢重编程相关标志物的潜力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Carbamoyl phosphate synthetase 1 (CPS1) is primarily expressed in hepatocytes as a highly abundant mitochondrial matrix enzyme that catalyses the first step of the urea cycle that leads to renal nitrogen disposal. CPS1 is a member of the CPS family that manifests broad evolutionary expression from bacteria to humans. CPS1 expression and enzyme activity are highly regulated transcriptionally and post-translationally. Its autosomal recessive mutation leads to CPS1 deficiency, which causes encephalopathy and coma, typically neonatally, due to severe hyperammonaemia. CPS1 is physiologically secreted, apically, into bile likely via mitochondria-derived vesicles. Normally absent from serum, it is released by basolateral mistargeting and cellular injury and becomes readily detectable in serum during acute liver failure (ALF). Injury-triggered CPS1 release into blood, or media in cultured hepatocytes, is selective as compared with other mitochondrial proteins. This, coupled with its abundance and short (1-2 hours) serum half-life, renders it a prognostic serum biomarker, particularly in human acetaminophen-related ALF. Its rapid turnover is explained by its non-enzymatic role as an immune modulator via its uptake by circulating monocytes leading to differentiation of anti-inflammatory cells that home to, and protect, the injured liver. CPS1 also plays a growing role in several cancers, by CPS1 upregulation or downregulation, particularly via metabolic reprogramming which alters the tumour microenvironment and impacts cancer growth and progression. Therefore, CPS1 has multiple enzymatic and non-enzymatic touch points spanning a wide range of cellular and extracellular functions and roles, with important physiological, homoeostatic, genetic disease, diagnostic and potential therapeutic clinical implications.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Chen L, Li P, Park MJ, et al. CPS1: a multipurpose mitochondrial enzyme, bile protein, acute liver injury biomarker, and cytokine. Gut. 2026. PMID: 41629147. doi:10.1136/gutjnl-2024-333082

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。